JHP Pharmaceuticals Enters Agreement to Produce Unique Late Stage Ophthalmic Product

PARSIPPANY, N.J., Sept. 16, 2013 /PRNewswire/ -- JHP Pharmaceuticals, a leading provider of global contract manufacturing services for sterile products, is pleased to announce that it has entered into a manufacturing agreement with an undisclosed pharmaceutical company which has developed proprietary products that provide sustained and localized drug concentration. The agreement is for technical transfer, registration batch manufacture and commercial supply of a unique late stage ophthalmic product.

JHP's manufacturing expertise and cGMP compliance history were critical factors in the selection process. Stuart Hinchen, President and CEO stated, "This important product has critical manufacturing requirements. We have successfully manufactured and filled a number of different products over the past few years, all with unique parameters. Our experience in this area provides our customers with a sound resource as the product moves through launch and commercialization. Our record of cGMP compliance driven by experienced quality and regulatory teams continues to be one of the key reasons customers chose JHP."

Hinchen noted, "JHP is now expanding its manufacturing capabilities by introducing a new ophthalmic filling line that will further enhance production effectiveness. This innovative equipment will offer a disposable filling circuit, reduced line losses and broader product handling capabilities all in a restricted access configuration. At the moment, the new filling line is under construction and is expected to be fully operational during the second half of 2014."

JHP Pharmaceuticals, located in Rochester, Michigan, has over 27 years' experience in contract manufacturing. It has developed many partnerships in its history manufacturing clinical and commercial products. JHP has successfully supported launches of several products in US and international markets. Currently it manufactures products for sale in 86 countries.

About JHP Pharmaceuticals, LLC

JHP Pharmaceuticals, headquartered in New Jersey, provides contract manufacturing of sterile products including biologics, small molecule, controlled substances, vaccines, ophthalmics, otics and antibiotics for large and small pharmaceutical and biotech organizations.

JHP's sterile manufacturing facility, located in Rochester Michigan sits on over 85 acres of land and includes a 171,000 sq. ft. production building and warehouse. The production facility utilizes three high-speed filling lines, a clinical filling line, an ophthalmic filling line and four lyophilizers. The site includes a new, innovatively-designed facility for chemistry, sterility testing and analytical methods development.

JHP has the capability to manufacture small-scale clinical through large-scale commercial products. JHP employs more than 400 staff in the USA in its manufacturing, product development, regulatory, sales and marketing and corporate areas. For more information, please visit www.jhppharma.com.

SOURCE JHP Pharmaceuticals